Issue Archive
June 2020 | Volume 19 | Issue 6
Editorials
Evaluation of Risk of Major Adverse Cardiovascular Events with Biologic Therapy in Patients with Psoriasis (Errata)
Erratum for "Evaluation of Risk of Major Adverse Cardiovascular Events with Biologic Therapy in Patients with Psoriasis." Retrieved from http://jddonline.com/articles/dermatology/S1545961617P1002X/
Safety surveillance for ustekinumab and other psoriasis treatments from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) Errata
Erratum for article "Safety surveillance for ustekinumab and other psoriasis treatments from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)." Retrieved from https://jddonline.com/art...
Read MoreSafety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): Experience with infliximab and other systemic and biologic therapies Errata
Erratum for article "Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): Experience with infliximab and other systemic and biologic therapies." Retriev...
Read MoreVirtual Exams No Substitute for In-Person Care of Acne and Rosacea
Original Articles
Treating Inflammation in Rosacea: Current Options and Unmet Needs
Rosacea is a disease resulting from dysregulation of innate, adaptive, and neurovascular immune systems. Inflammatory pathways activated in rosacea can explain many of its signs and symptoms. Current ...
Read MoreTreatment of Moderate to Severe Acne and Scars With a 650-Microsecond 1064-nm Laser and Isotretinoin
Background: Laser procedures for acne and acne scars have traditionally been postponed for at least 6 to 8 months after the end of systemic isotretinoin therapy. Lower dosages with more modern laser d...
Read MoreDevelopment of a Photonumeric Lip Health Scale
Background: The lips are important facial anatomic features with particular vulnerability to environmental damage, yet they have received little attention in the dermatologic literature. A photonumeri...
Read MoreDemographics and Baseline Disease Characteristics of Early Responders to Crisaborole for Atopic Dermatitis
Introduction: Crisaborole ointment, 2%, is a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild-to-moderate atopic dermatitis (AD). This post hoc, pooled analysis identified demograp...
Read MoreUnited States Stock Market Response to FDA Approval of New Dermatologic Drugs
Background: The Food and Drug Administration (FDA) has approved several new dermatologic drugs in the last decade. The public response to their approval has not yet been evaluated.
Objective: To ...
Read MoreThe New Psoriasis Paradigm: Striving for Complete Clearance
Newer biologics have introduced the possibility of higher and more complete clearance rates than previously possible. For many patients, PASI 90 and PASI 100 responses are realistic. Furthermore, high...
Read MoreConsensus on Neonatal Through Preadolescent Acne
Background: Acne vulgaris is the most common dermatological disorder. Pediatric acne may be a manifestation of the underlying pathology and can occur in the first weeks, months, or years of life. Acne...
Read MoreA Double-Blind, Comparative Clinical Study of Newly Formulated Retinol Serums vs Tretinoin Cream in Escalating Doses: A Method for Rapid Retinization With Minimized Irritation
Objective: The goal of this 12 week, double-blinded, controlled, clinical study was to compare the efficacy, tolerability, and consumer acceptance of three novel retinol serums to tretinoin.
Met...
Read MoreImproving the Appearance of Surgical Facial Scars With IncobotulinumtoxinA and Microneedling
Background: The appearance of post-surgical scars on the face is a major concern for surgeons and a source of anxiety for patients after Mohs surgery due to nonmelanoma skin cancer (NMSC). The objecti...
Read MoreNew Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis
Background: Acne vulgaris affects approximately 85% of adolescents. Topical tazarotene is efficacious and safe for acne treatment but irritation limits its use. The objective was to evaluate efficacy,...
Read MoreThe Effect of Isotretinoin on Vitiligo and Autoimmune Comorbidity
Several case reports have noted development of vitiligo as a potential side-effect of isotretinoin. In an IRB approved on-line survey of vitiligo patients we queried 1,301 vitiligo patients, 1115 with...
Read MoreNon-Steroidal Topical Therapy for Facial Seborrheic Dermatitis
Seborrheic dermatitis (SD) is a chronic, recurrent, inflammatory skin disorder occurring in areas rich in sebaceous glands. It manifests clinically as erythematous macules or plaques with varying leve...
Read More
Features
COVID-19 Supply Chain Considerations for Prescription Drugs in Dermatology
Biologics and Small Molecules in the Treatment of COVID-19
Considerations of Managing Lichen Planopilaris With Hydroxychloroquine During the COVID-19 Pandemic
Teaching Lessons from the Coronavirus Disease 2019 (COVID-19) Pandemic in Telemedicine
The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY...
Read MoreOutpatient Teledermatology Implementation During the COVID-19 Pandemic: Challenges and Lessons Learned
Evaluating Population Interest in Vitiligo Through an Analysis of Google Trends and Social Media
Assessing a Paradigm Shift: Perceptions of the USMLE Step 1 Scoring Change to Pass/Fail
